A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules

Clinical trial NCT02667938 · COMPLETED

Trial details

NCT number: NCT02667938
Sponsor: Hanmi Pharmaceutical Company Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia

Start date: 2015-03-01
Primary completion: 2016-01-01
Enrollment: 510

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.